Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,

Published byΦώτιος Χατζηιωάννου Modified over 5 years ago

Similar presentations

Presentation on theme: "Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,"— Presentation transcript:

1 Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin, Otto Cars  Clinical Microbiology and Infection  Volume 3, Issue 1, Pages (February 1997) DOI: /j tb00254.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

2 Fig. 1 Killing curves of imipenem, meropenem and BO-2727 at a concentration corresponding to that reached in serum after 1 h against Staphylococcus aureus. Mean of three experiments. Clinical Microbiology and Infection 1997 3, 73-81DOI: ( /j tb00254.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

3 Fig. 2 Killing curves of BO-2727 at different concentrations against Escherichia coli ATCC Mean of three experiments. Clinical Microbiology and Infection 1997 3, 73-81DOI: ( /j tb00254.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

4 Fig. 3 Killing curves of imipenem, meropenem and BO-2727 against non-growing Escherichia coli ATCC Mean of three experiments. Clinical Microbiology and Infection 1997 3, 73-81DOI: ( /j tb00254.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Download ppt "Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,"

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages 19-23.

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent.

Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent.
Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.

Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.
In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.

In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.
Gut bacterial microbiota and obesity

Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis

Approach to diagnosis of infective endocarditis
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,

Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Herpes zoster in non-hospitalized children

Herpes zoster in non-hospitalized children
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.

Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus  A. Carricajo,

In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus  A. Carricajo,
N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A

N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A
Cytokine response to staphylococcal exotoxins in Staphylococcus aureus septicemia  Bo Söderquist, Krysztof Kanclerski, Karl-Gössta Sundqvist, Patricia.

Cytokine response to staphylococcal exotoxins in Staphylococcus aureus septicemia  Bo Söderquist, Krysztof Kanclerski, Karl-Gössta Sundqvist, Patricia.
Louis Pasteur, from crystals of life to vaccination

Louis Pasteur, from crystals of life to vaccination

Similar presentations

Ads by Google